Association of body mass index (BMI) with progression-free survival (PFS) in patients with advanced renal cell cancer (RCC) treated with targeted therapies.
J. Dhaliwal
No relevant relationships to disclose
H. S. Gill
No relevant relationships to disclose
B. I. Chung
No relevant relationships to disclose
L. C. Harshman
Consultant or Advisory Role - Novartis
K. Rajan
No relevant relationships to disclose
S. Srinivas
Consultant or Advisory Role - Genentech; GlaxoSmithKline; Novartis; Pfizer